Clinical trials
Terminated Polycythemia Vera trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| CTI BioPharma | 2 |
| Exelixis | 2 |
| Mayo Clinic | 2 |
| Roswell Park Cancer Institute | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Baylor College of Medicine | 1 |
| City of Hope Medical Center | 1 |
| Consorzio Mario Negri Sud | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycythemia Vera | 32 |
| Primary Myelofibrosis | 24 |
| Thrombocythemia, Essential | 23 |
| Myeloproliferative Disorders | 21 |
| Leukemia, Myeloid, Acute | 11 |
| Leukemia | 10 |
| Leukemia, Myelomonocytic, Chronic | 10 |
| Myelodysplastic Syndromes | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Multiple Myeloma | 9 |
Trials
Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.